Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
April-2021 Volume 14 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2021 Volume 14 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases

  • Authors:
    • Taira Hada
    • Morikazu Miyamoto
    • Hiroki Ishibashi
    • Hiroko Matsuura
    • Takahiro Sakamoto
    • Soichiro Kakimoto
    • Hideki Iwahashi
    • Rie Suzuki
    • Hitoshi Tsuda
    • Masashi Takano
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359‑8513, Japan, Department of Pathology, National Defense Medical College Hospital, Tokorozawa, Saitama 359‑8513, Japan
  • Article Number: 75
    |
    Published online on: February 23, 2021
       https://doi.org/10.3892/mco.2021.2237
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to examine the clinical outcome of ovarian clear cell borderline tumor (CCBT) through pathological review for cases with clear cell carcinoma (CCC) and CCBT between 1984 and 2015 who received surgery at the National Defense Medical College Hospital using 2020 World Health Organization (WHO) criteria. In addition to the definition of CCBT in 2020 WHO criteria, clear cell with atypia of the glandular epithelium without fibromatous component was added to the diagnostic criteria of CCBT. Two cases with CCBT were identified through review in the current study. There were no cases that changed from the initial CCBT diagnosis that were included in the current study. Case 1 was a 43‑year‑old woman who received total hysterectomy, bilateral salpingo‑oophorectomy and partial omentectomy. Pathologically, cysts were lined by cuboidal, hobnail and clear cells with eosinophilic cytoplasm and moderate nuclear atypia without the fibromatous component. These cells were adjacent to atypical endometriosis and non‑atypical endometriosis, and the patient was diagnosed with CCBT. She exhibited no evidence of the disease for 37 months following surgery. Case 2 was a 42‑year‑old woman who received left salpingo‑­oophorectomy, partial omentectomy and pelvic lymphadenectomy. The tumor exhibited a cyst (80 mm) and nodular component. Pathologically, the tumor cells were lined by hobnail cells with mild atypia and eosinophilic cytoplasm without the fibromatous component. This patient was diagnosed with CCBT and exhibited no evidence of disease for 20 months following surgery. CCBT without fibromatous component is a rare and non‑aggressive histological subtype. Additionally, regardless of fibromatous component, CCBT was able to be diagnosed.
View Figures

Figure 1

Figure 2

View References

1 

Taylor HC Jr: Malignant and semimalignant tumors of the ovary. Surg Gynecol. 48:204–230. 1929.

2 

Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 50: 1-7, 1971.

3 

Serov SS, Scully RE and Sobin LH (eds); World Health Organization: Histological Typing of Ovarian Tumors. Springer, Berlin, Heidelberg, New York, NY, Geneva, 1973.

4 

Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, Silva E, Gorstein F and Young RH: Borderline ovarian tumors: Key points and workshop summary. Hum Pathol. 35:910–917. 2004.PubMed/NCBI View Article : Google Scholar

5 

Trimble CL, Kosary C and Trimble EL: Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 86:34–37. 2002.PubMed/NCBI View Article : Google Scholar

6 

Lokuhetty D, White VA and Cree IA (eds): WHO Classification of Tumours of Female Reproductive Organs. Lyon, IARC, Lyon, 2020.

7 

Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, Kajdacsy-Balla A, Berman DM and Copeland LJ: Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 35:918–933. 2004.PubMed/NCBI View Article : Google Scholar

8 

Suzuki A, Shiozawa T, Mori A, Kimura K and Konishi I: Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: Report of two cases and a possible new histological subtype. Gynecol Oncol. 101:540–544. 2006.PubMed/NCBI View Article : Google Scholar

9 

Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, Mendizabal E and Ortiz-Quintana L: International Federation of Gynecology and Obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: Estimation of survival in patients with node-positive epithelial ovarian cancer. Int J Gynecol Cancer. 25:49–54. 2015.PubMed/NCBI View Article : Google Scholar

10 

Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, Kajdacsy-Balla A, Berman DM and Copeland LJ: Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 35:918–933. 2004.PubMed/NCBI View Article : Google Scholar

11 

Hauptmann S, Friedrich K, Redline R and Avril S: Ovarian borderline tumors in the 2014 WHO classification: Evolving concepts and diagnostic criteria. Virchows Arch. 470:125–142. 2017.PubMed/NCBI View Article : Google Scholar

12 

Ohishi Y, Oda Y, Kurihara S, Kaku T, Yasunaga M, Nishimura I, Okuma E, Kobayashi H, Wake N and Tsuneyoshi M: Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms. Hum Pathol. 40:1168–1175. 2009.PubMed/NCBI View Article : Google Scholar

13 

Ohishi Y, Kurihara S, Aman M, Takeuchi T, Imamura H, Kaku T, Kobayashi H, Wake N and Oda Y: ‘Piling up’ clear cells in müllerian-type mucinous and mixed cell-type borderline tumor do not represent concomitant clear cell neoplasms. Hum Pathol. 43:1618–1626. 2012.PubMed/NCBI View Article : Google Scholar

14 

Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, et al: Ovarian carcinoma subtypes are different diseases: Implications for biomarker studies. PLoS Med. 5(e232)2008.PubMed/NCBI View Article : Google Scholar

15 

Kato N, Sasou S and Motoyama T: Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 19:83–89. 2006.PubMed/NCBI View Article : Google Scholar

16 

Kao GF and Norris HJ: Unusual cytadenofibromas: Endometrioid, mucinous, and clear cell types. Obstet Gynecol. 54:729–736. 1979.PubMed/NCBI

17 

Roth LM, Langley FA, Fox H, Wheeler JE and Czernobilsky B: Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer. 53:1156–1163. 1984.PubMed/NCBI View Article : Google Scholar

18 

Bell DA and Scully RE: Benign and borderline clear cell adenofibromas of the ovary. Cancer. 56:2922–2931. 1985.PubMed/NCBI View Article : Google Scholar

19 

Katsube Y, Fujiwara H, Tanioka Y, Imajo M and Fujiwara A: Ovarian clear cell adenofibroma of borderline malignancy. A case report. Hiroshima J Med Sci. 38:87–90. 1989.PubMed/NCBI

20 

Liu JL, Chu PY, Yeh KT and Huang RH: Borderline clear cell adenofibroma with extensive hemorrhagic necrosis. Hematol Oncol Stem Ther. 3:158–160. 2010.PubMed/NCBI View Article : Google Scholar

21 

Momotani K, Tnaka T, Iwai E, Kanda T, Munakata S and Ohmichi M: Ovarian clear cell adenofibromatous tumor of borderline malignancy associated with high levels of carbohydrate antigen 9-9. J Obstet Gynaecol Res. 37:472–477. 2011.PubMed/NCBI View Article : Google Scholar

22 

Zhao C, Wu LS and Barner R: Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: Clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer. 2:94–103. 2011.PubMed/NCBI View Article : Google Scholar

23 

Cakir E, Aydin E, Durmus NI, Samdanci E, Sahin N and Nurkabul Z: Primary ovarian clear cell adenofibroma of borderline malignancy. Oman Med J. 27(e031)2012.PubMed/NCBI View Article : Google Scholar

24 

Vasilakaki T, Skafida E, Arkoumani E, Grammatoglou X, Firfiris N and Manoloudaki K: Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: A case report. Eur J Gynarcol Oncol. 33:230–232. 2012.PubMed/NCBI

25 

Uzan C, Dufeu-Lefebvre M, Fauvet R, Gouy S, Duvillard P, Darai E and Morice P: Management and prognosis of clear cell borderline ovarian tumor. Int J Gynecol Cancer. 22:993–999. 2012.PubMed/NCBI View Article : Google Scholar

26 

Kleebkaow P, Aue-Aungkul A, Temtanakitpaisan A and Kietpeerakool C: Borderline clear cell adenofibroma of the ovary. Case Rep Pathol. 2017(3860107)2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Tsuda H, Takano M, Takano M, et al: Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases. Mol Clin Oncol 14: 75, 2021.
APA
Hada, T., Miyamoto, M., Ishibashi, H., Matsuura, H., Sakamoto, T., Kakimoto, S. ... Takano, M. (2021). Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases. Molecular and Clinical Oncology, 14, 75. https://doi.org/10.3892/mco.2021.2237
MLA
Hada, T., Miyamoto, M., Ishibashi, H., Matsuura, H., Sakamoto, T., Kakimoto, S., Iwahashi, H., Suzuki, R., Tsuda, H., Takano, M."Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases". Molecular and Clinical Oncology 14.4 (2021): 75.
Chicago
Hada, T., Miyamoto, M., Ishibashi, H., Matsuura, H., Sakamoto, T., Kakimoto, S., Iwahashi, H., Suzuki, R., Tsuda, H., Takano, M."Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases". Molecular and Clinical Oncology 14, no. 4 (2021): 75. https://doi.org/10.3892/mco.2021.2237
Copy and paste a formatted citation
x
Spandidos Publications style
Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Tsuda H, Takano M, Takano M, et al: Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases. Mol Clin Oncol 14: 75, 2021.
APA
Hada, T., Miyamoto, M., Ishibashi, H., Matsuura, H., Sakamoto, T., Kakimoto, S. ... Takano, M. (2021). Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases. Molecular and Clinical Oncology, 14, 75. https://doi.org/10.3892/mco.2021.2237
MLA
Hada, T., Miyamoto, M., Ishibashi, H., Matsuura, H., Sakamoto, T., Kakimoto, S., Iwahashi, H., Suzuki, R., Tsuda, H., Takano, M."Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases". Molecular and Clinical Oncology 14.4 (2021): 75.
Chicago
Hada, T., Miyamoto, M., Ishibashi, H., Matsuura, H., Sakamoto, T., Kakimoto, S., Iwahashi, H., Suzuki, R., Tsuda, H., Takano, M."Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases". Molecular and Clinical Oncology 14, no. 4 (2021): 75. https://doi.org/10.3892/mco.2021.2237
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team